HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
BMY
Bristol-Myers Squibb Company
Healthcare Drug Manufacturers - General · New York, USA · Reports in usd
Market Cap: $119.52B
Market Cap
$119.52B
Enterprise Val
$153.96B
P/E Ratio
16.94
P/B Ratio
6.47
Trailing PEG (1Y)
0.01
As Of
Apr 23, 2026

Overview & Key Metrics

Reporting period: Dec 31, 2025 · Q4 2025
Book Value$18.51B
Gross Margin67.23%
Profit Margin67.23%
Return on Equity39.27%
Return on Assets7.54%
Current Ratio1.26
Debt/Equity2.44
LT Debt/Equity2.32
Revenue Per Share6.14

Income Statement

Dec 31, 2025
Revenue$12.50B
Cost of Revenue$4.10B
Gross Profit$8.41B
R&D$2.59B
SG&A$2.18B
Operating Expenses$6.94B
Operating Income$1.47B
Interest Expense$0.00
Tax Expense$384.0M
Net Income$1.09B
EPS (Basic)$0.54
EPS (Diluted)$0.53
EBIT$1.47B
EBITDA$2.45B
Consolidated Income$1.09B
Non-Controlling Interests-$1.0M

Balance Sheet

Dec 31, 2025
Cash & Equivalents$10.21B
Accounts Receivable$11.41B
Inventory$2.69B
Current Assets$29.39B
LT Investments$396.0M
Property, Plant & Equipment$7.54B
Intangibles$40.86B
Non-Current Assets$60.65B
Total Assets$90.04B
Accounts Payable$3.58B
Current Debt$2.26B
Current Liabilities$23.42B
LT Debt$42.85B
Non-Current Liabilities$48.12B
Total Liabilities$71.53B
Total Debt$45.11B
Retained Earnings$16.90B
Shareholder Equity$18.47B
Shares Outstanding2,035,753,027

Cash Flow Statement

Dec 31, 2025
Operating Cash Flow$1.97B
Investing Cash Flow-$1.46B
Financing Cash Flow-$6.03B
CapEx-$370.0M
Free Cash Flow$1.60B
Depreciation & Amort.$977.0M
Stock-Based Comp$133.0M
Acquisitions / Disposals-$1.43B
Investment Activity$340.0M
Debt Issued/Repaid-$4.73B
Equity Issued/Repaid-$33.0M
Dividends Paid-$1.26B
Net Change in Cash-$5.51B
Data cached · Meta live · Daily live · Statements live · TTL 24h